[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Acer Therapeutics Inc (ACER)

Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K 16,149
  • Shares Outstanding, K 24,464
  • Annual Sales, $ 0 K
  • Annual Income, $ -26,240 K
  • EBIT $ -20 M
  • EBITDA $ -20 M
  • 60-Month Beta 0.44
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 3.66
  • Earnings Per Share ttm 0.22
  • Most Recent Earnings $-0.53 on 11/20/23
  • Next Earnings Date 01/06/25
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6000 +10.02%
on 11/09/23
0.9200 -28.25%
on 11/08/23
-0.1670 (-20.19%)
since 10/20/23
3-Month
0.5515 +19.69%
on 08/25/23
1.7599 -62.49%
on 08/31/23
-0.0669 (-9.20%)
since 08/18/23
52-Week
0.5515 +19.69%
on 08/25/23
4.5600 -85.52%
on 12/23/22
-0.5199 (-44.06%)
since 11/18/22

Most Recent Stories

More News
Moore Kuehn Encourages TWNK, LVOX, ACER, and PNT Investors to Contact Law Firm

/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...

LVOX : 3.73 (+0.81%)
ACER : 0.6601 (-17.95%)
TWNK : 33.30 (-0.15%)
PNT : 12.50 (+0.16%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AEL, HT, ABCM, ACER

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

ACER : 0.6601 (-17.95%)
ABCM : 23.99 (+0.04%)
AEL : 56.47 (+0.55%)
HT : 9.99 (-0.10%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ABCM, AGE, ACER, NXGN

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

ACER : 0.6601 (-17.95%)
ABCM : 23.99 (+0.04%)
NXGN : 23.94 (+0.13%)
AGE : 11.10 (-11.90%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates WRK, AGE, ACER

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

WRK : 51.51 (+3.54%)
ACER : 0.6601 (-17.95%)
AGE : 11.10 (-11.90%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates THRN, ABCM, AGE, ACER

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

ACER : 0.6601 (-17.95%)
ABCM : 23.99 (+0.04%)
THRN : 10.19 (-0.10%)
AGE : 11.10 (-11.90%)
Shareholder Alert: Ademi LLP investigates whether Acer Therapeutics Inc. has obtained a Fair Price in its transaction with Zevra

/PRNewswire/ -- Ademi LLP is investigating Acer (Nasdaq: ACER) for possible breaches of fiduciary duty and other violations of law in its transaction with...

ACER : 0.6601 (-17.95%)
SWK Holdings Provides Portfolio Update Highlighting Recent Achievements

/PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science focused specialty finance company catering to small- and...

AZYO : 1.4900 (+2.05%)
ACER : 0.6601 (-17.95%)
SWKH : 15.90 (-4.96%)
BTCY : 0.1003 (-12.25%)
BIOL : 0.0174 (-71.98%)
ETON : 48.79 (+1.37%)
Acer Therapeutics and Relief Therapeutics Announce Presentation of ACER-001 Data at the Genetic Metabolic Dieticians International Conference

NEWTON, MA and GENEVA, SWITZERLAND / ACCESSWIRE / May 6, 2022 / Acer Therapeutics Inc. (NASDAQ:ACER) ("Acer") and its collaboration partner, Relief Therapeutics Holding SA (SIX:RLF, OTCQB:RLFTF, RLFTY)...

ACER : 0.6601 (-17.95%)
RLFTY : 0.4225 (-75.62%)
RLFTF : 0.2340 (+3.40%)
Acer Therapeutics and Relief Therapeutics Announce Presentation of ACER-001 Data at the Society for Inherited Metabolic Disorders Annual Meeting

NEWTON, MA and GENEVA, SWITZERLAND / ACCESSWIRE / April 12, 2022 / Acer Therapeutics Inc. (NASDAQ:ACER) ("Acer") and its collaboration partner, Relief Therapeutics Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY)...

ACER : 0.6601 (-17.95%)
RLFTY : 0.4225 (-75.62%)
RLFTF : 0.2340 (+3.40%)
RELIEF THERAPEUTICS Holdings AG: Acer Therapeutics and Relief Therapeutics Announce Submission of a New Drug Application to the U.S. FDA for ACER-001 for Treatment of Urea Cycle Disorders

NEWTON, MA and GENEVA, SWITZERLAND / ACCESSWIRE / August 9, 2021 / Acer Therapeutics Inc. (NASDAQ:ACER) (" Acer "), a pharmaceutical company focused on the acquisition, development and commercialization...

ACER : 0.6601 (-17.95%)

Business Summary

Acer Therapeutics Inc. is a pharmaceutical company. It develops therapies for the treatment of ultra-rare diseases with critical unmet medical need. The company's product pipeline consists of Edsivo (TM) and ACER-001 which are in clinical stage. Acer Therapeutics Inc., formerly known as Opexa Therapeutics,...

See More

Key Turning Points

3rd Resistance Point 0.9766
2nd Resistance Point 0.9133
1st Resistance Point 0.7867
Last Price 0.6601
1st Support Level 0.5968
2nd Support Level 0.5335
3rd Support Level 0.4069

See More

52-Week High 4.5600
Fibonacci 61.8% 3.0288
Fibonacci 50% 2.5557
Fibonacci 38.2% 2.0827
Last Price 0.6601
52-Week Low 0.5515

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.